1. Haplofungins, novel inositol phosphorylceramide synthase inhibitors, from Lauriomyces bellulus SANK 26899 I. Taxonomy, fermentation, isolation and biological activities.
- Author
-
Ohnuki T, Yano T, Ono Y, Kozuma S, Suzuki T, Ogawa Y, and Takatsu T
- Subjects
- Antifungal Agents chemistry, Antifungal Agents isolation & purification, Antifungal Agents metabolism, Ascomycota classification, Ascomycota growth & development, Ascomycota isolation & purification, Candida glabrata drug effects, Candida glabrata enzymology, Enzyme Inhibitors chemistry, Enzyme Inhibitors metabolism, Fatty Acids, Unsaturated chemistry, Fatty Acids, Unsaturated isolation & purification, Fatty Acids, Unsaturated metabolism, Fermentation, Humans, Microbial Sensitivity Tests, Saccharomyces cerevisiae drug effects, Saccharomyces cerevisiae enzymology, Soil Microbiology, Structure-Activity Relationship, Antifungal Agents pharmacology, Ascomycota metabolism, Enzyme Inhibitors pharmacology, Fatty Acids, Unsaturated pharmacology, Hexosyltransferases antagonists & inhibitors
- Abstract
In the course of screening for antifungal agents, we have discovered eight novel compounds, haplofungin A, B, C, D, E, F, G and H, from a culture broth of the fungus strain Lauriomyces bellulus SANK 26899. Haplofungins are composed of an arabinonic acid moiety linked through an ester to a modified long alkyl chain and show potent inhibitory activities against fungal inositol phosphorylceramide (IPC) synthase. Haplofungin A inhibited the activity of IPC synthase from Saccharomyces cerevisiae with an IC(50) value of 0.0015 microg ml(-1). This inhibitor also suppressed the growth of Candida glabrata at the MIC value of 0.5 microg ml(-1).
- Published
- 2009
- Full Text
- View/download PDF